<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined the effect of recombinant IFN-alpha and IFN-gamma on induction of LAK cells from peripheral blood mononuclear cells (PBMNCs) in 7 pre-operative <z:hpo ids='HP_0003002'>breast cancer</z:hpo> patients and 4 healthy volunteers </plain></SENT>
<SENT sid="1" pm="."><plain>Significant LAK activity was developed from PBMNCs of pre-operative <z:hpo ids='HP_0003002'>breast cancer</z:hpo> patients and healthy volunteers after incubation for 4 days with IL-2 (presence of IL-2 vs. absence of IL-2) </plain></SENT>
<SENT sid="2" pm="."><plain>Incubation of PBMNCs of pre-operative <z:hpo ids='HP_0003002'>breast cancer</z:hpo> patients with 1000 U/ml of IFN-alpha for 4 days suppressed the LAK activity significantly (P &lt; 0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>By contrast, incubation of PBMNCs of pre-operative patients with 1000 U/ml of IFN-gamma for 4 days increased the LAK activity significantly (P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>Significant cytotoxicity against MCF-7 cells (<z:chebi fb="0" ids="50114">estrogen</z:chebi> receptor positive human <z:hpo ids='HP_0003002'>breast cancer</z:hpo> cell line) was developed from PBMNCs of pre-operative <z:hpo ids='HP_0003002'>breast cancer</z:hpo> patients at 20:1 and 40:1 E/T ratios after incubation for 4 days with IL-2 (absence of IL-2 vs. 20:1 or 40:1, P &lt; 0.05, P &lt; 0.05), whereas PBMNCs of healthy volunteers did not </plain></SENT>
<SENT sid="5" pm="."><plain>Stimulation of LAK cells with IFN-gamma produced a significant augmentation of cytotoxic activity against MCF-7 (P &lt; 0.05), while IFN-alpha suppressed the cytotoxicity significantly (P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>These findings suggested that combined stimulation by IFN-gamma and IL-2 might be a reasonable treatment for <z:hpo ids='HP_0003002'>breast cancer</z:hpo> patients </plain></SENT>
</text></document>